Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | UNK | — |
hasn't received any other doses since; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. Previously administered products included Menveo (received a first dose on 20-JUL-2021, lot no AMXA517A). On an unknown date, the patient did not receive the 2nd dose of Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced incomplete course of vaccination (Verbatim: hasn't received any other doses since). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 23-APR-2025 The pharmacist reported that a patient received a first dose of Menveo 4 years ago and hasn't received any other doses since. The pharmacist mentioned patient required now to complete the Menveo schedule due to a soliris infusion. Till the time of reporting, the patient did not receive 2nd dose of Menveo, which led to incomplete course of vaccination.